Funding for this research was provided by:
Received: 9 May 2022
Accepted: 4 September 2022
First Online: 29 September 2022
: WCG IRB (Puyallup, WA, USA) served as the IRB. IRB approval was obtained to review the deidentified physician notes. Patient privacy was preserved, and strict compliance with relevant Health Insurance Portability and Accountability Act data handling rules was observed throughout.
: Not applicable.
: AA is an employee of Optum. ALB reports grants from Amicus/Scioderm, Amryt Pharma, Castle Creek/Fibrocell, Phoenix Tissue Repair, and Phoenics. BC is an employee of Optum. JAF is Chair of the State of Colorado Medicaid Pharmacy and Therapeutics Committee. JR was an employee of Krystal Biotech when this study was conducted.